Published in Cell Mol Neurobiol on February 01, 1999
Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation (2004) 2.91
Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc Natl Acad Sci U S A (2000) 1.15
Chronic traumatic encephalopathy: clinical-biomarker correlations and current concepts in pathogenesis. Mol Neurodegener (2014) 1.15
Apolipoprotein E and traumatic brain injury in a military population: evidence of a neuropsychological compensatory mechanism? J Neurol Neurosurg Psychiatry (2007) 0.94
Neurochemical profile of dementia pugilistica. J Neurotrauma (2013) 0.82
Chronic thrombin exposure results in an increase in apolipoprotein-E levels. J Neurosci Res (2006) 0.78
Clinical, cognitive, and genetic predictors of change in job status following traumatic brain injury in a military population. J Head Trauma Rehabil (2009) 0.77
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature (1987) 17.08
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (1991) 16.77
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A (1993) 15.04
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology (1993) 14.54
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (1995) 13.80
Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science (1995) 8.31
Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science (1987) 6.89
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A (1989) 5.97
The aftermath of boxing. Psychol Med (1973) 4.92
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 4.86
Apolipoprotein E polymorphism and Alzheimer's disease. Lancet (1993) 4.47
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett (1992) 4.29
Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature (1994) 4.28
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology (1995) 3.91
Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol (1985) 3.83
Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med (1995) 3.77
Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. Ann Neurol (1995) 3.34
Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science (1992) 3.14
Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1992) 2.84
Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem (1994) 2.66
Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet (1994) 2.65
Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.63
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet (1993) 2.57
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A (1989) 2.48
Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? Immunol Today (1991) 2.41
beta A4 amyloid protein deposition in brain after head trauma. Lancet (1991) 2.41
The occult aftermath of boxing. J Neurol Neurosurg Psychiatry (1990) 2.41
Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol (1995) 2.35
Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc Natl Acad Sci U S A (1992) 2.31
Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry (1994) 2.24
Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci (1994) 1.92
Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet (1994) 1.85
Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet (1994) 1.83
Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci (1988) 1.78
S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. J Neurosci Res (1994) 1.52
Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem (1994) 1.46
Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol (1996) 1.46
Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol (1993) 1.42
Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Res Mol Brain Res (1992) 1.41
Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol Aging (1992) 1.39
Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol (1994) 1.36
Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci Lett (1994) 1.32
Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J Biol Chem (1995) 1.29
Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron (1995) 1.28
Distribution of beta-amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol (1995) 1.28
Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology (1992) 1.27
Dementia in a punch-drunk wife. Lancet (1990) 1.21
Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci Lett (1991) 1.18
Post-traumatic Alzheimer's disease: preponderance of a single plaque type. Neuropathol Appl Neurobiol (1991) 1.13
Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. Methods Find Exp Clin Pharmacol (1994) 1.06
Molecular pathology of head trauma: altered beta APP metabolism and the aetiology of Alzheimer's disease. Prog Brain Res (1993) 0.99
ApoE epsilon 4 allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis. Neurology (1994) 0.98
Alzheimer's disease: pathology to potential treatments? Trends Pharmacol Sci (1992) 0.95
Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain. Brain Res (1995) 0.93
Increased numbers of beta APP-immunoreactive neurones in the entorhinal cortex after head injury. Neuroreport (1994) 0.92
Molecular genetics of Alzheimer disease: identification of genes and gene mutations. Eur Neurol (1995) 0.91
Beta-amyloid precursor protein gene is differentially expressed in axotomized sensory and motor systems. Brain Res Mol Brain Res (1991) 0.89
Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer's beta-amyloid protein precursor in the brain. Brain Res (1994) 0.87
Quantification of beta APP immunoreactive pre-alpha cells in the entorhinal cortex using image analysis. Neurodegeneration (1995) 0.75
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med (1995) 3.77
ABDOMINAL INCISIONS TREATED BY THE "OPEN METHOD". Ann Surg (1927) 3.34
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med (1997) 2.95
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol (1998) 2.73
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
Association of apolipoprotein E polymorphism with outcome after head injury. Lancet (1997) 2.57
beta A4 amyloid protein deposition in brain after head trauma. Lancet (1991) 2.41
The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging. Neuropathol Appl Neurobiol (2007) 2.38
Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol (2000) 2.37
Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett (1993) 2.35
Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol (1995) 2.35
Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry (1994) 2.24
Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study. Pediatr Pulmonol (2001) 2.20
"Life, Jim, but not as we know it"? Transmissible dementias and the prion protein. Br J Psychiatry (1991) 2.16
Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging (2001) 2.00
Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol (2000) 1.99
Neuronal cytoskeletal changes are an early consequence of repetitive head injury. Acta Neuropathol (1999) 1.93
Cranial chordomas in children and adolescents. J Neurosurg (1996) 1.90
A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol (2001) 1.77
Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology (2000) 1.76
Recent advances in neurotrauma. J Neuropathol Exp Neurol (2000) 1.68
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry (1999) 1.63
In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging (1997) 1.60
Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.56
Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol (1995) 1.53
S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. J Neurosci Res (1994) 1.52
Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages. J Neuropathol Exp Neurol (1997) 1.51
How now mad cow? BMJ (1992) 1.49
Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci (2000) 1.48
Choline acetyltransferase in schizophrenia. Am J Psychiatry (1993) 1.47
Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem (1994) 1.46
Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol (1996) 1.46
Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration (1995) 1.45
Prion-protein immunoreactivity in human transmissible dementias. N Engl J Med (1986) 1.42
Diagnosis and incidence of prion (Creutzfeldt-Jakob) disease: a retrospective archival survey with implications for future research. Neurodegeneration (1995) 1.40
Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J Neuropathol Exp Neurol (2000) 1.40
Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol Aging (1992) 1.39
Decline in incidence of medulloblastoma in children. Cancer (1994) 1.38
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38
Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol (1994) 1.36
The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol Aging (2000) 1.35
Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci Lett (1994) 1.32
The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol (1999) 1.31
Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol (1997) 1.31
Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid beta-protein of Alzheimer's disease. Am J Pathol (1990) 1.30
Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol (1998) 1.29
Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem Int (2001) 1.29
Distribution of beta-amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol (1995) 1.28
S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim Biophys Acta (1994) 1.24
Non-Hodgkin's lymphoma presenting with spinal cord compression; a clinicopathological review of 25 cases. Eur J Cancer (2000) 1.22
S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J Neurochem (1998) 1.22
Amyloid beta-protein, APOE genotype and head injury. Ann N Y Acad Sci (1996) 1.21
The nature, distribution and causes of traumatic brain injury. Brain Pathol (1995) 1.21
Dementia in a punch-drunk wife. Lancet (1990) 1.21
Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochem Int (2001) 1.19
The neuroinflammatory response in humans after traumatic brain injury. Neuropathol Appl Neurobiol (2013) 1.18
Tissue adenosine content in active soleus and gracilis muscles of cats. Am J Physiol (1983) 1.17
Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp Neurol (2000) 1.17
Axonal injury: a universal consequence of fatal closed head injury? Acta Neuropathol (1995) 1.17
Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol Aging (1996) 1.16
Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res (2001) 1.15
A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. Neuroreport (1997) 1.15
Markers of axonal injury in post mortem human brain. Acta Neuropathol (1994) 1.14
Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy. J Neurochem (1995) 1.14
Prion protein immunocytochemistry--UK five centre consensus report. Neuropathol Appl Neurobiol (1997) 1.13
Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis. Neurobiol Aging (1999) 1.13
Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease. Acta Neurochir Suppl (1996) 1.13
Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol (1995) 1.13